Search:

Obesity raises recurrence risk of prostate cancer (Reuters)

Reuters - Obese men have an increased risk of cancer recurrence after undergoing treatment with radiotherapy for localized prostate cancer, new research shows.

More: continued here

Leave a Reply

Powered by Article Dashboard

Related News


  • Obesity In Prostate Cancer Patients Predicts Cancer Recurrence And Progression
    Obesity in a patient is an independent predictor of whether localized prostate cancer will progress following radiotherapy treatment, say researchers at M. D. Anderson Cancer Center.In a study reported in the Aug. 1 issue of the journal Cancer, researchers found that moderately and severely obese patients had a 99 percent greater risk of developing biochemical failure (an early marker of cancer progression) than other patients. [click link for full article]


  • Prostate patients ‘have needless surgery’
    Radical treatment for prostate cancer is a waste of time for most men, scientists have claimed.They said surgery or radiotherapy does little to improve survival chances but can lead to impotence and incontinence. Read the facts on prostate cancer here


  • Obesity Is Associated With Less Favorable Outcome After Radiation Therapy For Prostate Cancer
    Obese men with prostate cancer are at higher risk for treatment failure after primary radiation therapy, according to a new study. Published in the August 1, 2006 issue of CANCER (http://www.interscience.wiley. [click link for full article]


  • Obesity, blood glucose tied to enlarged prostate (Reuters)
    Reuters - BPH, or benign prostate hyperplasia, is a common condition in older men, but the risk of developing the condition seems to be increased by obesity and high blood sugar levels, researchers report.


  • ‘Artificial light increases breast cancer risk’
    Women who sleep with the light on or stay up late at night could be at a greater risk of breast cancer, according to scientists. Researchers have long suggested that being exposed to too much light at night disrupts crucial hormones and raises the chance of developing breast tumours